ArQule, Inc. (ARQL)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on ArQule, Inc. (ARQL)
16 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on ARQL
- Alan Brochstein(5)
- Bespoke Investment Group(3)
- Ohad Hammer(3)
- Lon Juricic(1)
- H.S. Ayoub(1)
Most popular authors
(tracked in watchlists)
- Bespoke Investment Group(679)
- Alan Brochstein(222)
- Mike Havrilla(165)
- Ohad Hammer(46)
- Eben Tessari (24)
Most commented on authors
- Ohad Hammer(19)
- Alan Brochstein(15)
- Michael Becker(2)
- Lon Juricic(0)
- H.S. Ayoub(0)
- 2009: Positive Outlook for Biotech
- Navigating the Micro-Cap Biotech Minefield
- ArQule Joins Forces with Daiichi Sankyo to Fight Cancer
- Arqule’s Theater of the Absurd
- 'When There's Blood in the Streets', Buy Biotech Stocks
- Licensing Deal Is Imminent for ArQule
- S&P 1500 Stocks With the Largest Intraday Spreads
- S&P 1500 Stocks With the Largest Intraday Spreads
- Cancer Stocks Hammered Once Again
- Cancer Stocks Slide Again
- Stocks With the Largest Intraday High-Low Ranges
- Cancer Stocks Plunge Following ASCO Meeting
- Cancer Stocks Soar With Annual ASCO Meeting
- Cancer Stocks on the Go: Winners and Losers
- ArQule Could Gain Ahead of American Society of Clinical Oncology Meeting
- ArQule, Inc.: Millenco Boosts Stake to 6.3%
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
1 new today)